Skip to main content
Logo

Funding

We have demonstrated that sustained investment in African science holds the potential for strong and long-term impact. We fund game changing ideas and innovations to transform Africa

Funding Opportunities.

6 opportunities available

Deadline:

This is a practical skills and cultural learning programme for both the African and UK research managers with support from their institutions to integrate the lessons learned. The aim is not only to build capacity, but to also strengthen collaboration and knowledge exchange among the institutions.

Deadline:

The entire Programme package maximally strives to strengthen the fellow’s skills and capacities and, upon return of the fellow, contribute to the creation of qualitative clinical development centres of excellence at sites across sub-Saharan Africa, and on the long run contribute to prosperity and welfare of the continent.

Deadline:

The AAS Affiliates live out the Academy’s vision of transforming lives through sciences in their research and leadership excellence. They actively contribute to the programme activities while also motivating other young researchers to pursue scientific excellence.

Deadline:

The first cohort of eight drug discovery scientists was successfully awarded, in June 2019, after a rigorous selection process. This is therefore an invitation to be part of the second next phase of support for the drug discovery call 2020.

Deadline:

Proposals are invited for short-term projects addressing and mitigating the health, social, economic, cultural and environmental impacts of the COVID-19 outbreak in Low and Middle Income Countries1.

Deadline:

The ELA conference targets AAS Fellows, Affiliates, and grantees undertaking research in East and West Africa to provide a platform for sharing lessons in evidence-informed decision making practices across Science, Technology and Innovation (STI) sectors in Africa. 

Other Funding Opportunities

2 opportunities available

Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed)

Award value – N/A

Deadline – 

The purpose of this Funding Opportunity Announcement (FOA) is to provide an expedited funding mechanism for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). NIAID is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS, for 2019 Novel Coronavirus (COVID-19).

Link -  Read More

Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed)

Award value – N/A

Deadline – 

The purpose of this Funding Opportunity Announcement (FOA) is to provide an expedited funding mechanism for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). NIAID is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS, for 2019 Novel Coronavirus (COVID-19).

Link -  Read More